Read More Pharma Industry News Pfizer’s ADCETRIS combination regimen secures FDA approval for relapsed large B-cell lymphoma The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc.’s supplemental Biologics License Application (sBLA) for ADCETRIS… byPallavi MadhirajuFebruary 12, 2025